VRTX 内幕交易
VRTX 的 SEC Form 4 内幕交易记录
总交易
199
买入
0
买入总额
-
卖出总额
$135.6M
| 信号 | 内幕人 | 职位 | 方向 | 股数 | 价格 | 金额 | 日期 | 信号原因 |
|---|---|---|---|---|---|---|---|---|
| ★★★★★(55) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 40,000 | $493.47 | $19.7M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(50) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 15,580 | $495.38 | $7.7M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(45) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 3,498 | $494.33 | $1.7M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(45) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 5,995 | $496.16 | $3.0M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(45) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 3,278 | $488.27 | $1.6M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(45) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 2,510 | $487.13 | $1.2M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(45) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 2,520 | $493.29 | $1.2M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(45) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 2,725 | $490.54 | $1.3M | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(40) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 1,725 | $496.95 | $857K | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(35) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 949 | $491.30 | $466K | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(35) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 240 | $482.84 | $116K | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(35) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 400 | $479.75 | $192K | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(35) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 460 | $489.32 | $225K | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(35) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 120 | $481.50 | $58K | 2026-02-27 | CEO卖出, 董事卖出 |
| ★★★★★(33) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 5,193 | $424.25 | $2.2M | 2026-05-06 | 高管卖出, 百万级卖出 |
| ★★★★★(33) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 58,613 | $468.83 | $27.5M | 2026-02-19 | 高管卖出, 巨额卖出(>$10M) |
| ★★★★★(31) | BOZIC CARMEN | EVP and CMO | 卖出 | 6,988 | $450.00 | $3.1M | 2026-05-12 | 高管卖出, 百万级卖出 |
| ★★★★★(31) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 2,437 | $489.46 | $1.2M | 2026-02-17 | 高管卖出, 百万级卖出 |
| ★★★★★(30) | SACHS BRUCE I | - | 卖出 | 1,210 | $547.55 | $663K | 2026-08-27 | 董事卖出, 大额卖出(>$500K) |
| ★★★★★(28) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 11,712 | $470.54 | $5.5M | 2026-02-19 | 高管卖出, 超大额卖出(>$5M) |
| ★★★★★(28) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 19,662 | $468.57 | $9.2M | 2026-02-19 | 高管卖出, 超大额卖出(>$5M) |
| ★★★★★(23) | BOZIC CARMEN | EVP and CMO | 卖出 | 4,062 | $450.00 | $1.8M | 2026-06-15 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | BOZIC CARMEN | EVP and CMO | 卖出 | 2,329 | $450.95 | $1.1M | 2026-03-27 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | BOZIC CARMEN | EVP and CMO | 卖出 | 2,329 | $481.79 | $1.1M | 2026-03-13 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 2,633 | $498.42 | $1.3M | 2026-03-11 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 2,437 | $475.30 | $1.2M | 2026-03-04 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | BOZIC CARMEN | EVP and CMO | 卖出 | 2,329 | $480.31 | $1.1M | 2026-02-27 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 2,410 | $489.00 | $1.2M | 2026-02-25 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 2,500 | $486.35 | $1.2M | 2026-02-25 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 4,910 | $487.65 | $2.4M | 2026-02-25 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 2,730 | $465.05 | $1.3M | 2026-02-19 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 10,263 | $467.75 | $4.8M | 2026-02-19 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 7,241 | $469.61 | $3.4M | 2026-02-19 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 4,237 | $471.43 | $2.0M | 2026-02-19 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 2,476 | $489.46 | $1.2M | 2026-02-17 | 高管卖出, 百万级卖出 |
| ★★★★★(23) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 4,500 | $474.99 | $2.1M | 2026-01-07 | 高管卖出, 百万级卖出 |
| ★★★★★(18) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 1,541 | $519.00 | $800K | 2026-07-02 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 1,500 | $524.99 | $787K | 2026-07-02 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | BOZIC CARMEN | EVP and CMO | 卖出 | 1,745 | $450.00 | $785K | 2026-06-05 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | BOZIC CARMEN | EVP and CMO | 卖出 | 1,974 | $450.00 | $888K | 2026-05-29 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | BOZIC CARMEN | EVP and CMO | 卖出 | 1,354 | $453.45 | $614K | 2026-05-15 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 1,846 | $486.35 | $898K | 2026-02-25 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 1,848 | $465.80 | $861K | 2026-02-19 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 1,244 | $473.68 | $589K | 2026-02-18 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 1,182 | $473.68 | $560K | 2026-02-18 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 1,557 | $489.46 | $762K | 2026-02-17 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 2,031 | $489.46 | $994K | 2026-02-17 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 1,500 | $499.99 | $750K | 2026-02-13 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 2,021 | $460.43 | $931K | 2026-02-11 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 1,376 | $460.43 | $634K | 2026-02-11 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 1,751 | $460.43 | $806K | 2026-02-11 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(18) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 1,925 | $460.43 | $886K | 2026-02-11 | 高管卖出, 大额卖出(>$500K) |
| ★★★★★(15) | BHATIA SANGEETA N. | - | 卖出 | 318 | $423.73 | $135K | 2026-05-04 | 董事卖出, S&P500成分股 |
| ★★★★★(15) | BHATIA SANGEETA N. | - | 卖出 | 266 | $500.00 | $133K | 2026-02-13 | 董事卖出, S&P500成分股 |
| ★★★★★(13) | LIU JOY | EVP and Chief Legal Officer | 卖出 | 828 | $502.71 | $416K | 2026-07-01 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | BOZIC CARMEN | EVP and CMO | 卖出 | 596 | $482.50 | $288K | 2026-06-26 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | BOZIC CARMEN | EVP and CMO | 卖出 | 1,020 | $462.17 | $471K | 2026-06-18 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | LIU JOY | EVP and Chief Legal Officer | 卖出 | 828 | $439.91 | $364K | 2026-06-01 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 33 | $453.45 | $15K | 2026-05-15 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | LIU JOY | EVP and Chief Legal Officer | 卖出 | 1,104 | $425.02 | $469K | 2026-05-01 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | LIU JOY | EVP and Chief Legal Officer | 卖出 | 978 | $449.17 | $439K | 2026-04-01 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | LIU JOY | EVP and Chief Legal Officer | 卖出 | 892 | $495.96 | $442K | 2026-03-02 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 357 | $483.36 | $173K | 2026-02-26 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 945 | $486.35 | $460K | 2026-02-25 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 223 | $486.35 | $108K | 2026-02-25 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 260 | $486.35 | $126K | 2026-02-25 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 668 | $486.35 | $325K | 2026-02-25 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 620 | $486.35 | $302K | 2026-02-25 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 920 | $463.91 | $427K | 2026-02-19 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 368 | $473.68 | $174K | 2026-02-18 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 638 | $473.68 | $302K | 2026-02-18 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 817 | $473.68 | $387K | 2026-02-18 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 609 | $489.46 | $298K | 2026-02-17 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 988 | $499.00 | $493K | 2026-02-13 | 高管卖出, S&P500成分股 |
| ★★★★★(13) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 466 | $460.43 | $215K | 2026-02-11 | 高管卖出, S&P500成分股 |
| ★★★★★(0) | BRENNAN DANIEL J. | - | 卖出 | 795 | $503.47 | $400K | 2026-10-20 | |
| ★★★★★(0) | GARBER ALAN M | - | 卖出 | 29 | $512.44 | $15K | 2026-10-15 | |
| ★★★★★(0) | SACHS BRUCE I | - | 卖出 | 93 | $512.44 | $48K | 2026-10-15 | |
| ★★★★★(0) | VAN GRUNSVEN JASPER | EVP, CP and NPPO | 卖出 | 8,682 | - | - | 2026-09-08 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 5,000 | - | - | 2026-08-28 | |
| ★★★★★(0) | SACHS BRUCE I | - | 卖出 | 6,000 | - | - | 2026-08-27 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 8,251 | - | - | 2026-07-21 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 8,251 | - | - | 2026-07-21 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 0 | - | - | 2026-07-21 | |
| ★★★★★(0) | SACHS BRUCE I | - | 卖出 | 100 | $475.28 | $48K | 2026-07-15 | |
| ★★★★★(0) | GARBER ALAN M | - | 卖出 | 32 | $475.28 | $15K | 2026-07-15 | |
| ★★★★★(0) | THORNBERRY NANCY | - | 卖出 | 398 | - | - | 2026-05-01 | |
| ★★★★★(0) | MCKENZIE DIANA | - | 卖出 | 0 | - | - | 2026-05-01 | |
| ★★★★★(0) | MCKENZIE DIANA | - | 卖出 | 943 | - | - | 2026-05-01 | |
| ★★★★★(0) | SCHNEIDER JENNIFER | - | 卖出 | 1,433 | - | - | 2026-05-01 | |
| ★★★★★(0) | BHATIA SANGEETA N. | - | 卖出 | 943 | - | - | 2026-05-01 | |
| ★★★★★(0) | UPADHYAY SUKETU | - | 卖出 | 796 | - | - | 2026-05-01 | |
| ★★★★★(0) | GARBER ALAN M | - | 卖出 | 1,433 | - | - | 2026-05-01 | |
| ★★★★★(0) | GARBER ALAN M | - | 卖出 | 472 | - | - | 2026-05-01 | |
| ★★★★★(0) | LAGARDE MICHEL | - | 卖出 | 2,866 | - | - | 2026-05-01 | |
| ★★★★★(0) | SCHNEIDER JENNIFER | - | 卖出 | 472 | - | - | 2026-05-01 | |
| ★★★★★(0) | SCHNEIDER JENNIFER | - | 卖出 | 796 | - | - | 2026-05-01 | |
| ★★★★★(0) | THORNBERRY NANCY | - | 卖出 | 1,433 | - | - | 2026-05-01 | |
| ★★★★★(0) | UPADHYAY SUKETU | - | 卖出 | 2,866 | - | - | 2026-05-01 | |
| ★★★★★(0) | UPADHYAY SUKETU | - | 卖出 | 796 | - | - | 2026-05-01 | |
| ★★★★★(0) | THORNBERRY NANCY | - | 卖出 | 398 | - | - | 2026-05-01 | |
| ★★★★★(0) | MCKENZIE DIANA | - | 卖出 | 796 | - | - | 2026-05-01 | |
| ★★★★★(0) | SACHS BRUCE I | - | 卖出 | 2,866 | - | - | 2026-05-01 | |
| ★★★★★(0) | CARNEY LLOYD | - | 卖出 | 2,866 | - | - | 2026-05-01 | |
| ★★★★★(0) | THORNBERRY NANCY | - | 卖出 | 472 | - | - | 2026-05-01 | |
| ★★★★★(0) | MCKENZIE DIANA | - | 卖出 | 796 | - | - | 2026-05-01 | |
| ★★★★★(0) | SCHNEIDER JENNIFER | - | 卖出 | 796 | - | - | 2026-05-01 | |
| ★★★★★(0) | GARBER ALAN M | - | 卖出 | 34 | $442.50 | $15K | 2026-04-15 | |
| ★★★★★(0) | SACHS BRUCE I | - | 卖出 | 107 | $442.50 | $47K | 2026-04-15 | |
| ★★★★★(0) | UPADHYAY SUKETU | - | 卖出 | 81 | $442.50 | $36K | 2026-04-15 | |
| ★★★★★(0) | LIU JOY | EVP and Chief Legal Officer | 卖出 | 0 | - | - | 2026-03-01 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 546 | $485.11 | $265K | 2026-02-24 | |
| ★★★★★(0) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 582 | $485.11 | $282K | 2026-02-24 | |
| ★★★★★(0) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 1,144 | $485.11 | $555K | 2026-02-24 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 1,627 | $485.11 | $789K | 2026-02-24 | |
| ★★★★★(0) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 873 | $485.11 | $424K | 2026-02-24 | |
| ★★★★★(0) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 1,627 | $485.11 | $789K | 2026-02-24 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 1,518 | $485.11 | $736K | 2026-02-24 | |
| ★★★★★(0) | LEIDEN JEFFREY M | Executive Chairman | 卖出 | 0 | - | - | 2026-02-24 | |
| ★★★★★(0) | BOZIC CARMEN | EVP and CMO | 卖出 | 1,453 | $485.11 | $705K | 2026-02-24 | |
| ★★★★★(0) | LEIDEN JEFFREY M | Executive Chairman | 卖出 | 3,547 | $485.11 | $1.7M | 2026-02-24 | |
| ★★★★★(0) | WAGNER CHARLES F JR | EVP, CO & FO | 卖出 | 1,744 | $485.11 | $846K | 2026-02-24 | |
| ★★★★★(0) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 4,981 | $485.11 | $2.4M | 2026-02-24 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 0 | - | - | 2026-02-24 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 23,479 | $155.57 | $3.7M | 2026-02-19 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 25,026 | $187.53 | $4.7M | 2026-02-19 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 0 | - | - | 2026-02-19 | |
| ★★★★★(0) | LEIDEN JEFFREY M | Executive Chairman | 卖出 | 2,964 | $483.75 | $1.4M | 2026-02-18 | |
| ★★★★★(0) | WAGNER CHARLES F JR | EVP, CO & FO | 卖出 | 2,294 | $483.75 | $1.1M | 2026-02-17 | |
| ★★★★★(0) | LEIDEN JEFFREY M | Executive Chairman | 卖出 | 8,269 | - | - | 2026-02-17 | |
| ★★★★★(0) | BOZIC CARMEN | EVP and CMO | 卖出 | 1,912 | $483.75 | $925K | 2026-02-17 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 2,294 | $483.75 | $1.1M | 2026-02-17 | |
| ★★★★★(0) | LEIDEN JEFFREY M | Executive Chairman | 卖出 | 0 | - | - | 2026-02-17 | |
| ★★★★★(0) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 4,962 | - | - | 2026-02-17 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 5,789 | - | - | 2026-02-17 | |
| ★★★★★(0) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 1,505 | $483.75 | $728K | 2026-02-17 | |
| ★★★★★(0) | WAGNER CHARLES F JR | EVP, CO & FO | 卖出 | 7,365 | - | - | 2026-02-17 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 0 | - | - | 2026-02-17 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 5,789 | - | - | 2026-02-17 | |
| ★★★★★(0) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 1,148 | $483.75 | $555K | 2026-02-17 | |
| ★★★★★(0) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 4,962 | - | - | 2026-02-17 | |
| ★★★★★(0) | BOZIC CARMEN | EVP and CMO | 卖出 | 5,375 | - | - | 2026-02-17 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 1,809 | - | - | 2026-02-17 | |
| ★★★★★(0) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 1,530 | $483.75 | $740K | 2026-02-17 | |
| ★★★★★(0) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 4,135 | - | - | 2026-02-17 | |
| ★★★★★(0) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 16,326 | - | - | 2026-02-17 | |
| ★★★★★(0) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 6,554 | $483.75 | $3.2M | 2026-02-17 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 2,140 | $483.75 | $1.0M | 2026-02-17 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 598 | $483.75 | $289K | 2026-02-17 | |
| ★★★★★(0) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 1,110 | $483.75 | $537K | 2026-02-17 | |
| ★★★★★(0) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 2,584 | - | - | 2026-02-17 | |
| ★★★★★(0) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 13,041 | $487.76 | $6.4M | 2026-02-13 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 3,548 | $487.76 | $1.7M | 2026-02-13 | |
| ★★★★★(0) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 2,283 | $487.76 | $1.1M | 2026-02-13 | |
| ★★★★★(0) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 2,993 | $487.76 | $1.5M | 2026-02-13 | |
| ★★★★★(0) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 2,283 | $487.76 | $1.1M | 2026-02-13 | |
| ★★★★★(0) | BOZIC CARMEN | EVP and CMO | 卖出 | 3,804 | $487.76 | $1.9M | 2026-02-13 | |
| ★★★★★(0) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 1,903 | $487.76 | $928K | 2026-02-13 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 1,393 | $487.76 | $679K | 2026-02-13 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 3,804 | $487.76 | $1.9M | 2026-02-13 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 0 | - | - | 2026-02-13 | |
| ★★★★★(0) | WAGNER CHARLES F JR | EVP, CO & FO | 卖出 | 4,565 | $487.76 | $2.2M | 2026-02-13 | |
| ★★★★★(0) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 1,630 | $468.41 | $764K | 2026-02-10 | |
| ★★★★★(0) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 8,297 | $468.41 | $3.9M | 2026-02-10 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 2,140 | $468.41 | $1.0M | 2026-02-10 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 0 | - | - | 2026-02-10 | |
| ★★★★★(0) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 1,127 | $468.41 | $528K | 2026-02-10 | |
| ★★★★★(0) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 872 | $468.41 | $408K | 2026-02-10 | |
| ★★★★★(0) | WAGNER CHARLES F JR | EVP, CO & FO | 卖出 | 3,045 | $468.41 | $1.4M | 2026-02-10 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 2,057 | $468.41 | $964K | 2026-02-10 | |
| ★★★★★(0) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 1,127 | $468.41 | $528K | 2026-02-10 | |
| ★★★★★(0) | BOZIC CARMEN | EVP and CMO | 卖出 | 2,145 | $468.41 | $1.0M | 2026-02-10 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 592 | $468.41 | $277K | 2026-02-10 | |
| ★★★★★(0) | BUNNAGE MARK E. | EVP, Chief Scientific Officer | 卖出 | 0 | - | - | 2026-02-01 | |
| ★★★★★(0) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 2,774 | - | - | 2026-01-22 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 1,300 | - | - | 2026-01-22 | |
| ★★★★★(0) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 4,720 | - | - | 2026-01-22 | |
| ★★★★★(0) | ALTSHULER DAVID | EVP, Chief Scientific Officer | 卖出 | 3,328 | - | - | 2026-01-22 | |
| ★★★★★(0) | ALTSHULER DAVID | EVP, Chief Scientific Officer | 卖出 | 7,866 | - | - | 2026-01-22 | |
| ★★★★★(0) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 3,883 | - | - | 2026-01-22 | |
| ★★★★★(0) | BOZIC CARMEN | EVP and CMO | 卖出 | 7,866 | - | - | 2026-01-22 | |
| ★★★★★(0) | LEIDEN JEFFREY M | Executive Chairman | 卖出 | 9,012 | - | - | 2026-01-22 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 7,866 | - | - | 2026-01-22 | |
| ★★★★★(0) | AMBROSE KRISTEN | SVP & Chief Accounting Officer | 卖出 | 2,950 | - | - | 2026-01-22 | |
| ★★★★★(0) | BOZIC CARMEN | EVP and CMO | 卖出 | 3,467 | - | - | 2026-01-22 | |
| ★★★★★(0) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 26,972 | - | - | 2026-01-22 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 0 | - | - | 2026-01-22 | |
| ★★★★★(0) | ATKINSON EDWARD MORROW III | EVP, Chief Technical Ops. Off. | 卖出 | 3,934 | - | - | 2026-01-22 | |
| ★★★★★(0) | KEWALRAMANI RESHMA | CEO & President | 卖出 | 11,885 | - | - | 2026-01-22 | |
| ★★★★★(0) | WAGNER CHARLES F JR | EVP, CO & FO | 卖出 | 4,160 | - | - | 2026-01-22 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 7,866 | - | - | 2026-01-22 | |
| ★★★★★(0) | SACHDEV AMIT | EVP Chief Patient & Ext Af Off | 卖出 | 3,883 | - | - | 2026-01-22 | |
| ★★★★★(0) | WAGNER CHARLES F JR | EVP, CO & FO | 卖出 | 9,440 | - | - | 2026-01-22 | |
| ★★★★★(0) | LEIDEN JEFFREY M | Executive Chairman | 卖出 | 0 | - | - | 2026-01-22 | |
| ★★★★★(0) | BILLER JONATHAN | EVP and Chief Legal Officer | 卖出 | 6,294 | - | - | 2026-01-22 | |
| ★★★★★(0) | MCKECHNIE DUNCAN | EVP, Chief Commercial Officer | 卖出 | 2,080 | - | - | 2026-01-22 | |
| ★★★★★(0) | TATSIS OURANIA | EVP, Chief Reg. & Quality Off. | 卖出 | 3,883 | - | - | 2026-01-22 | |
| ★★★★★(0) | UPADHYAY SUKETU | - | 卖出 | 80 | $443.56 | $35K | 2026-01-15 | |
| ★★★★★(0) | SACHS BRUCE I | - | 卖出 | 107 | $443.56 | $47K | 2026-01-15 |